Catherine T. Vu, M.D., F.S.I.R. for UC Davis Health

Catherine T. Vu, M.D., F.S.I.R.

Chief, Division of Vascular and Interventional Radiology


To see if Catherine T. Vu is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).



Vascular and Interventional Radiology

Radiology - Vascular

Radiology - Interventional Radiology



Locations and Contact

Lawrence J. Ellison Ambulatory Care Center

4860 Y St.
Sacramento, CA 95817

Get Directions

Additional Numbers

Clinic Phone


Clinic Fax


Physician Referrals

800-4-UCDAVIS (800-482-3284)

Philosophy of Care

Interventional Radiology (IR) is a thriving field, delivering minimally invasive treatment over a spectrum of health care needs, from cancer therapy to acute injury management in trauma.

Treatments that historically require open surgery can be performed with needles and catheters using image guidance, such as ultrasound, CT and fluoroscopy. IR is at the helm of "leading edge" medicine. Patients turn to us when they seek treatment alternatives to surgery.

I place quality and patient-centered care at the forefront, providing pre-procedure consultation and post-procedure management. I work collaboratively with primary care providers, as well as all medical and surgical specialties.

Clinical Interests

Dr. Vu's specific clinical interests are:

  • Prostate artery embolization (PAE) for benign prostatic hypertrophy (BPH)
  • Targeted cancer therapies
  • Acute and chronic venous interventions
  • Dialysis management
  • Women's health.

She partners with Urology to offer prostate artery embolization (PAE) as a non-surgical treatment option for lower urinary tract symptoms (LUTS) and/or hematuria for patients with BPH.

She works with hepatologists and oncology specialists to provide multi-disciplinary care for patients with primary liver cancer (HCC) and metastatic disease to the liver, offering selective internal radiation therapy (Y-90 SIRT, also known as radioembolization), trans-arterial chemoembolization (TACE), and percutaneous thermal ablations.

She has a comprehensive venous practice, offering minimally invasive techniques in the treatment of venous diseases, including advanced IVC filter retrieval, venous re-canalization for chronic lower extremity deep venous thrombosis (DVT), May-Thurner syndrome, and complex venous access options for hemodialysis patients.

The scope of her women's health practice includes uterine fibroid embolization and pelvic congestion syndrome.


Vascular and Interventional Radiology

Center/Program Affiliation

Vascular Center

Undergraduate School

B.S., University of San Francisco, San Francisco CA 1994

Medical School

M.D., George Washington University School of Medicine, Washington DC 2006


Preliminary Medicine, Georgetown/Washington Hospital Center, Washington DC 2006-2007


Diagnostic Radiology, University of Colorado, Denver CO 2007-2011


Interventional Radiology, University of Colorado, Denver CO 2011-2012

M.D., Distinctive Graduate (top 15%), The George Washington University School, 2006

Taebi A, Vu CT, Roncali E. Multi-scale computational fluid dynamics modeling for personalized liver cancer radioembolization dosimetry. J Biomech Eng. 2020;143(1):011002 (12 pages). doi:10.1115/1.4047656.

Taebi A, Pillai RM, Roudsari BS, Vu CT, Roncali E. Computational Modeling of the Liver Arterial Blood Flow for Microsphere Therapy: Effect of Boundary Conditions. Bioengineering (Basel). 2020 Jun 29;7(3):64. doi:10.3390/bioengineering7030064. PMID:32610459.

Roncali E, Taebi A, Foster C, Vu CT. Personalized Dosimetry for Liver Cancer Y-90 Radioembolization Using Computational Fluid Dynamics and Monte Carlo Simulation. Ann Biomed Eng. 2020 May;48(5):1499-1510. doi:10.1007/s10439-020-02469-1. Epub 2020 Jan 31. PMID:32006268.

Roncali E, Taebi A, Spencer B, Coelho Alves Costa G, Rusnak M, Caudle D, Roudsari B, Pillai R, Foster C, Vu C. Comparison of Y-90 liver dose distribution predicted with fluid dynamics with Y-90 PET. J Nucl Med. 2020;61(supple_1):1308.

Taebi A, Roudsari B, Vu C, Cherry S, Roncali E. Hepatic arterial tree segmentation: Towards patient-specific dosimetry for liver cancer radioembolization. J Nucl Med. 2019;60:122.

Roudsari B, Said M, Vu CT, Pillai R. Evaluation of the Statewide Variability in the Current Role of Different Specialties in Lower Extremity Endovascular Revascularization for Medicare Beneficiaries. J Vasc Interv Radiol. 2019 Feb;30(2):250-256.e1. doi:10.1016/j.jvir.2018.10.029. PMID:30717959.

Chen L, DeMattos A, Bang H, Vu CT, Gandhi M, Alnimri M, Gallay B, Fananapazir G. Angioplasty versus stent in TRAS. Clinical Transplantation. Epub 2018 Feb 2. doi:10.1111/ctr.13217

Fananapazir G, Bashir MR, Corwin MT, Lamba R, Vu CT, Troppmann C. Comparison of ferumoxytol-enhanced MRA with conventional angiography for assessment of severity of transplant renal artery stenosis. J Magn Reson Imaging. 2017 Mar;45(3):779-785. doi:10.1002/jmri.25421. Epub 2016 Aug 9. PMID:27504713.

Fananapazir G, Troppmann C, Corwin MT, Bent CK, Vu CT, Lamba R. Incidence of Contrast-Induced Nephropathy After Renal Graft Catheter Arteriography Using Iodine-Based Contrast Medium. AJR Am J Roentgenol. 2016 Apr:206(4):783-6. doi:10.2214/AJR.15.15501. Epub 2016 Feb 11. PMID:26866337.

Bent C, Fananapazir G, Tse G, Corwin MT, Vu C, Santhanakrishnan C, Perez RV, Troppmann C. Graft arterial stenosis in kidney en bloc grafts from very small pediatric donors: incidence, timing, and role of ultrasound in screening. Am J Transplant. 2015 Nov;15(11):2940-6. doi:10.1111/ajt.13365. Epub 2015 Jul 7. PMID:26153092.